Cargando…
Oncolytic Viruses as Anticancer Vaccines
Oncolytic virotherapy has shown impressive results in preclinical studies and first promising therapeutic outcomes in clinical trials as well. Since viruses are known for a long time as excellent vaccination agents, oncolytic viruses are now designed as novel anticancer agents combining the aspect o...
Autores principales: | Woller, Norman, Gürlevik, Engin, Ureche, Cristina-Ileana, Schumacher, Anja, Kühnel, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104469/ https://www.ncbi.nlm.nih.gov/pubmed/25101244 http://dx.doi.org/10.3389/fonc.2014.00188 |
Ejemplares similares
-
Virus infections in tumors pave the way for tumor-directed DC-vaccines
por: Woller, Norman, et al.
Publicado: (2012) -
p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication
por: Gürlevik, Engin, et al.
Publicado: (2009) -
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
por: Niemann, Julia, et al.
Publicado: (2019) -
Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
por: Tai, Lee-Hwa, et al.
Publicado: (2014) -
Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)